Last checked at 6 Jul 2021 11:55
6 July 2021
Microsaic Systems plc
("Microsaic" or "Company")
Investor Presentation
Microsaic (AIM: MSYS), the developer of point of need mass spectrometry ("MS") systems and solutions, is pleased to announce that Glenn Tracey, CEO, and Bevan Metcalf, FD, will provide a live presentation relating to the trading update for H1 2021 (announced on 6 July 2021) via the Investor Meet Company platform on 8 July 2021 at 1:00 pm BST.
The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 9.00 am BST the day before the meeting or at any time during the live presentation.
Investors can sign up to Investor Meet Company for free and add to meet Microsaic Systems plc via:
https://www.investormeetcompany.com/microsaic-systems-plc/register-investor
Investors who already follow Microsaic Systems plc on the Investor Meet Company platform will automatically be invited.
Enquiries: | |
Microsaic Systems plc Glenn Tracey, CEO Bevan Metcalf, FD | +44 (0)1483 751 577 |
N+1 Singer (Nominated Adviser & Joint Broker) | +44 (0)20 7496 3000 |
Aubrey Powell / George Tzimas (Investment Banking)
| |
Turner Pope Investments (TPI) Limited (Joint Broker) Andy Thacker / James Pope | +44 (0) 20 3657 0050 |
About Microsaic (www.microsaic.com)
Microsaic listed on AIM in 2011 to develop and commercialise micro-engineering chip-based mass spectrometry equipment. Having invested £30m over the last 20 years before and after the IPO, Microsaic has a robust patent portfolio in cutting-edge technology purpose built for "Industry 4.0" which enables analytical detection and characterisation at the point-of-need, whether within a human health environment, conventional laboratory setting, or within a bioprocessing facility for continuous mass spectrometer detection and monitoring of data at any step in the process workflow.
Microsaic's products and systems are commercially available through global markets via a network of regional and local partners, targeting its core laboratory, manufacturing, and point-of-need applications.